{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02476786",
            "orgStudyIdInfo": {
                "id": "201611010"
            },
            "organization": {
                "fullName": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "briefTitle": "Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score",
            "officialTitle": "Endocrine Treatment Alone as Primary Treatment for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "endocrine-treatment-alone-for-elderly-patients-with-estrogen-receptor-positive-operable-breast-cancer-and-low-recurrence-score"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-01-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2031-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2015-06-17",
            "studyFirstSubmitQcDate": "2015-06-17",
            "studyFirstPostDateStruct": {
                "date": "2015-06-19",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Genomic Health\u00ae, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Multiple neoadjuvant endocrine trials demonstrate that women with good prognosis tumors can be identified. These trials have also demonstrated that there are not adverse effects on overall outcome if women are treated with neoadjuvant endocrine therapy for several months prior to definitive treatment. A new standard of care needs to be defined for elderly women with good prognosis estrogen receptor (ER)+ tumors, since these women may benefit from endocrine therapy alone to treat their cancer without compromising local and distant control. The investigators hypothesize that endocrine therapy alone provides adequate local and systemic control of breast cancer in a subpopulation of women 70 or older with ER+ breast cancer and low Ki67 scores."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer",
                "Cancer of Breast",
                "Breast Neoplasms",
                "Cancer of the Breast"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Endocrine therapy alone",
                    "type": "EXPERIMENTAL",
                    "description": "* Neoadjuvant endocrine therapy will be given at the discretion of the treating physician as directed by the package insert and could include the following: goserelin, anastrozole, letrozole, exemestane, fulvestrant, or tamoxifen\n* Frequency of office visits will be decided by the treating physician but must occur no less frequently than every 3 to 6 months for tumor assessment\n* After 6 months and after 12 months, patients will be assessed; patients who progress will have standard care recommended , and at any point a patient can opt to receive standard care even if she has not progressed on neoadjuvant endocrine therapy\n* Information on quality of life will be collected at baseline, Year 1, and Year 2 by the FACT-B questionnaire\n* Archival tissue will be collected and sent to Genomic Health for analysis using the Oncotype DX assay. The Recurrence Score predicts chemotherapy benefit and indicates the 10-year risk of recurrence (will not be used to determine treatment)",
                    "interventionNames": [
                        "Behavioral: FACT-B",
                        "Drug: Goserelin",
                        "Drug: Anastrozole",
                        "Drug: Exemestane",
                        "Drug: Fulvestrant",
                        "Drug: Tamoxifen",
                        "Other: Archived tissue collection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "FACT-B",
                    "description": "The FACT-B (Version 4) is a 37-item measure that contains the four general subscales along with the Breast Cancer-Specific subscale that assesses symptoms/concerns of particular relevance to breast cancer (e.g., body image, arm swelling and tenderness).",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Goserelin",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ],
                    "otherNames": [
                        "Goserelin acetate",
                        "Zoladex"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Anastrozole",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ],
                    "otherNames": [
                        "Arimidex\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Exemestane",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ],
                    "otherNames": [
                        "Aromasin\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fulvestrant",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ],
                    "otherNames": [
                        "Faslodex\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tamoxifen",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ],
                    "otherNames": [
                        "Nolvadex\u00ae"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Archived tissue collection",
                    "armGroupLabels": [
                        "Endocrine therapy alone"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Response rate",
                    "description": "* Response and progression will be evaluated in this study using the new international criteria proposed by the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) \\[Eur J Ca 45:228-247, 2009\\].\n* In each RECIST response category Oncotype DX scores will be summarized with mean, standard deviation, minimum, 1st, 2nd (median) and 3rd quartiles, and maximum values. OncotypeDx scores range from 0 to 100, with scores \\<18 indicating low risk.",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Breast cancer-specific survival",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Breast cancer-specific survival",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Breast cancer-specific survival",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Rate of overall survival",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed histologically or cytologically confirmed operable invasive breast cancer defined as cT1 or T2, N0-1, and M0.\n* Disease must be ER+ and HER2-.\n* Ki67 score/proliferative index \u2264 30% or low to intermediate mitotic index\n* Measurable disease defined as lesions that can be accurately measured in at least one dimension (longest diameter to be recorded) by ultrasound or mammogram.\n* 70 years of age or older.\n* ECOG performance status \u2264 3\n* Able to understand and willing to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).\n\nExclusion Criteria:\n\n* Prior surgery for this cancer\n* A history of other malignancy \u2264 5 years previous which would preclude endocrine treatment of their cancer.\n* Currently receiving any other investigational agents.\n* A history of allergic reactions attributed to compounds of similar chemical or biologic composition to any of the agents used in the study.\n* Uncontrolled intercurrent illness as determined by their treating physician which would limit compliance with study requirements.\n* Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with endocrine therapies. Appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when indicated.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "70 Years",
            "stdAges": [
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rebecca L Aft, M.D., Ph.D.",
                    "role": "CONTACT",
                    "phone": "314-747-0063",
                    "email": "aftr@wustl.edu"
                },
                {
                    "name": "Tracie Guthrie",
                    "role": "CONTACT",
                    "phone": "314-747-4404",
                    "email": "guthriet@wustl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rebecca L Aft, M.D, Ph.D.",
                    "affiliation": "Washington University School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rebecca L Aft, M.D., Ph.D.",
                            "role": "CONTACT",
                            "phone": "314-747-0063",
                            "email": "aftr@wustl.edu"
                        },
                        {
                            "name": "Tracey Guthrie",
                            "role": "CONTACT",
                            "phone": "314-747-4404",
                            "email": "guthriet@wustl.edu"
                        },
                        {
                            "name": "Rebecca L Aft, M.D., Ph.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Foluso Ademuyiwa, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Ron Bose, M.D., Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Andrew Davis, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "William Gillanders, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Cynthia X Ma, M.D., Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Julie Margenthaler, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Rama Suresh, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Katherine N Weilbaecher, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Ashley Frith, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Peter Oppelt, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Antonella Rastelli, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Caron Rigden, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Lindsay Peterson, M.D.",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Fei Wan, Ph.D.",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine",
                    "url": "http://www.siteman.wustl.edu"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000012008",
                    "term": "Recurrence"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "asFound": "Recurrence",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013629",
                    "term": "Tamoxifen"
                },
                {
                    "id": "D000077267",
                    "term": "Fulvestrant"
                },
                {
                    "id": "D000077384",
                    "term": "Anastrozole"
                },
                {
                    "id": "D000017273",
                    "term": "Goserelin"
                },
                {
                    "id": "C000056516",
                    "term": "Exemestane"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004965",
                    "term": "Estrogen Antagonists"
                },
                {
                    "id": "D000006727",
                    "term": "Hormone Antagonists"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000020845",
                    "term": "Selective Estrogen Receptor Modulators"
                },
                {
                    "id": "D000020847",
                    "term": "Estrogen Receptor Modulators"
                },
                {
                    "id": "D000050071",
                    "term": "Bone Density Conservation Agents"
                },
                {
                    "id": "D000065171",
                    "term": "Estrogen Receptor Antagonists"
                },
                {
                    "id": "D000047072",
                    "term": "Aromatase Inhibitors"
                },
                {
                    "id": "D000065088",
                    "term": "Steroid Synthesis Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19568",
                    "name": "Goserelin",
                    "asFound": "Participating",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1743",
                    "name": "Letrozole",
                    "relevance": "LOW"
                },
                {
                    "id": "M1723",
                    "name": "Fulvestrant",
                    "asFound": "Challenge",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8116",
                    "name": "Estrogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M16403",
                    "name": "Tamoxifen",
                    "asFound": "Ratio",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1781",
                    "name": "Anastrozole",
                    "asFound": "BAY",
                    "relevance": "HIGH"
                },
                {
                    "id": "M247237",
                    "name": "Exemestane",
                    "asFound": "Admitted",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8114",
                    "name": "Estrogen Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M30483",
                    "name": "Estrogen Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M22599",
                    "name": "Estrogen Receptor Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M22597",
                    "name": "Selective Estrogen Receptor Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M25769",
                    "name": "Aromatase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}